propranolol has been researched along with Liver Steatosis in 4 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To quantify the various components of splanchnic free fatty acid and very-low-density lipoprotein-triacylglycerol (VLDL-TAG) metabolism in order to gain insight into the mechanisms responsible for the development of fatty liver in severely burned patients, and to determine if decreasing free fatty acid availability by use of propranolol could potentially reduce hepatic fatty acid accumulation." | 3.71 | Propranolol decreases splanchnic triacylglycerol storage in burn patients receiving a high-carbohydrate diet. ( Herndon, DN; Irtun, O; Morio, B; Wolfe, RR, 2002) |
| " Studies were undertaken using an in situ-perfused rat liver and multiple indicator dilution, and outflow data were analyzed with a physiologically based organ pharmacokinetic model." | 1.37 | Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis. ( Crawford, DH; Fletcher, LM; Li, P; Roberts, MS; Robertson, TA; Thorling, CA; Zhang, Q, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, P | 1 |
| Robertson, TA | 1 |
| Thorling, CA | 1 |
| Zhang, Q | 1 |
| Fletcher, LM | 1 |
| Crawford, DH | 1 |
| Roberts, MS | 1 |
| McKee, C | 1 |
| Soeda, J | 1 |
| Asilmaz, E | 1 |
| Sigalla, B | 1 |
| Morgan, M | 1 |
| Sinelli, N | 1 |
| Roskams, T | 1 |
| Oben, JA | 1 |
| Walldorf, J | 1 |
| Hillebrand, C | 1 |
| Aurich, H | 1 |
| Stock, P | 1 |
| Hempel, M | 1 |
| Ebensing, S | 1 |
| Fleig, WE | 1 |
| Seufferlein, T | 1 |
| Dollinger, MM | 1 |
| Christ, B | 1 |
| Morio, B | 1 |
| Irtun, O | 1 |
| Herndon, DN | 1 |
| Wolfe, RR | 1 |
4 other studies available for propranolol and Liver Steatosis
| Article | Year |
|---|---|
Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Cations; Cytochrome P-450 | 2011 |
Propranolol, a β-adrenoceptor antagonist, worsens liver injury in a model of non-alcoholic steatohepatitis.
Topics: Adrenergic beta-Antagonists; Alanine Transaminase; Animals; Apoptosis; Choline; Culture Media; Disea | 2013 |
Propranolol impairs liver regeneration after partial hepatectomy in C57Bl/6-mice by transient attenuation of hepatic lipid accumulation and increased apoptosis.
Topics: Animals; Apoptosis; Blotting, Western; Cell Cycle; Fatty Liver; G1 Phase; Hepatectomy; Hepatocytes; | 2010 |
Propranolol decreases splanchnic triacylglycerol storage in burn patients receiving a high-carbohydrate diet.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Burns; Child; Child, Preschool; Dietary Carbohydrate | 2002 |